Mobile

A 4 week, randomized, vehicle-controlled, multicenter evaluation of the efficacy and safety of 1% pimecrolimus cream in adult patients with perioral dermatitis followed by a 8 week treatment free obse...

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-002058-23

A 4 week, randomized, vehicle-controlled, multicenter evaluation of the efficacy and safety of 1% pimecrolimus cream in adult patients with perioral dermatitis followed by a 8 week treatment free observation phase in responders

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To confirm the efficacy of pimecrolimus cream 1% in patients with perioral dermatitis, by testing the hypothesis that pimecrolimus cream 1% is superior in the mean reduction of the PODSI score (Perioral Dermatitis Severity Index) at weeks 1, 2 and 4 of treatment compared to its vehicle.

Critère d'inclusion

  • perioral dermatitis

Liens